[1-(2-Fluorobenzyl]cyclopropyl)methylamine hydrochloride, 1g

(3aR,8aS)-2-(Isoquinolin-1-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

2-(tert-Butoxycarbonyl)benzoic acid, 97.0%, 10g

(3R)-(+)-3-(tert-Butoxycarbonylamino)pyrrolidine, 99.0%, 10g

6-Methyl-5-nitropyridin-2-ol, 97.0%, 10g

3-(Pyridin-4-yl)-propionic acid, 95.0%, 250mg

Ethyl 2,2,2-trichloroacetate, 95.0%, 100g

(S)-Ethyl 2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoate, 95%, 250mg

n-Pentane, min. 95%, ultra pure, 100 ml, glass packaging

(S)-1-Boc-3-N-(Pyridin-4-ylmethyl)-amino-piperidine, 97.0%, 1g

2-Bromo-3-(2-ethylhexyl)-5-iodothiophene (stabilized with Copper chip)>97.0%(GC)1g

5-Methyl-benzo[b]thiophene-2-carboxylic acid ethyl ester, 95.0%, 25g

6-BROMOQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 5g